Cargando…

Trends in the Treatment of Anemia Using Recombinant Human Erythropoietin in Patients with HIV Infection

BACKGROUND: Treating anemia with erythropoietin (EPO) to hemoglobin (Hb) endpoints >11 g/dL may increase risk of serious adverse cardiovascular events. METHODS: We used medical records data (1996-2003 from the Adolescent Spectrum of HIV Disease Project [ASD] and 1996-2006 from the HIV Outpatient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sullivan, Patrick S, Hanson, Debra L, Richardson, James T, Brooks, John T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257553/ https://www.ncbi.nlm.nih.gov/pubmed/22253666 http://dx.doi.org/10.2174/1874613601105010113

Ejemplares similares

Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity
por: Saeidi, R, et al.
Publicado: (2012)

Impact of inflammation on anemia of hemodialysis patients who were under treatment of recombinant human erythropoietin
por: Rafiean-Kopaie, Mahmoud, et al.
Publicado: (2013)

The Efficacy of Recombinant Human Erythropoietin in Treatment Chemotherapy Induced Anemia in Children Diagnosed with a Solid Cancer
por: Hiradfar, AA, et al.
Publicado: (2014)

Science review: Recombinant human erythropoietin in critical illness: a role beyond anemia?
por: Coleman, Thomas, et al.
Publicado: (2004)

Trends in Use, Cost, and Outcomes of Human Recombinant Erythropoietin, 1989-98
por: Greer, Joel W., et al.
Publicado: (1999)

Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study
por: Fattizzo, Bruno, et al.
Publicado: (2020)

Treatment of Anemia in Kidney Disease: Beyond Erythropoietin
por: Wish, Jay B.
Publicado: (2021)

Effect of Zinc Supplementation on Renal Anemia in 5/6-Nephrectomized Rats and a Comparison with Treatment with Recombinant Human Erythropoietin
por: Feng, Hui-Lin, et al.
Publicado: (2019)

Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia
por: Garrido, Patrícia, et al.
Publicado: (2015)

Efficacy and safety of recombinant human erythropoietin (Hema-Plus(®)) for management of anemia in Thai patients on peritoneal dialysis
por: Chuengsaman, Piyatida, et al.
Publicado: (2021)

The Clinical Impact of Recombinant Human Erythropoietin
por: Muirhead, N
Publicado: (1997)

Erythropoietin in the intensive care unit: beyond treatment of anemia
por: Patel, Nimesh SA, et al.
Publicado: (2011)

Recombinant Human Erythropoietin Therapy for a Jehovah's Witness Child With Severe Anemia due to Hemolytic-Uremic Syndrome
por: Woo, Da Eun, et al.
Publicado: (2016)

Pharmacokinetics of PEGylated Recombinant Human Erythropoietin in Rats
por: Cao, Xiaohan, et al.
Publicado: (2014)

Recombinant Erythropoietin in Humans Has a Prolonged Effect on Circulating Erythropoietin Isoform Distribution
por: Aachmann-Andersen, Niels Jacob, et al.
Publicado: (2014)

Effects of Adjuvant Androgen on Anemia and Nutritional Parameters in Chronic Hemodialysis Patients Using Low-dose Recombinant Human Erythropoietin
por: Lee, Myeung Su, et al.
Publicado: (2002)

Scaling Pharmacodynamics from Rats to Humans to Support Erythropoietin and Romiplostim Combination Therapy to Treat Erythropoietin-Resistant Anemia
por: Fan, Xiaoqing, et al.
Publicado: (2023)

Preoperative recombinant human erythropoietin in anemic surgical patients
por: Monk, Terri G
Publicado: (2004)

Recombinant human erythropoietin therapy in critically ill patients
por: Georgopoulos, D, et al.
Publicado: (2005)

Modified recombinant human erythropoietin with potentially reduced immunogenicity
por: Susantad, Thanutsorn, et al.
Publicado: (2021)

Erythropoietin and Cancer: The Unintended Consequences of Anemia Correction
por: Debeljak, Nataša, et al.
Publicado: (2014)

Erythropoietin and iron for anemia in HIV-infected patients undergoing maintenance hemodialysis in China: a cross-sectional study
por: Peng, Lei, et al.
Publicado: (2022)

Effects of Recombinant Erythropoietin on Hemoglobin Levels and Blood Transfusion Needs in Patients with Preoperative Anemia Undergoing Cardiac Surgery
por: Totonchi, Ziae, et al.
Publicado: (2022)

P1482: RECOMBINANT ERYTHROPOIETIN IN AUTOIMMUNE HEMOLYTIC ANEMIA WITH INADEQUATE RETICULOCYTOSIS: A SINGLE CENTER PROSPECTIVE STUDY
por: Luca Pedone, Giacinto, et al.
Publicado: (2023)

Recombinant human erythropoietin for treating severe traumatic brain injury
por: Bai, Xiao-Fei, et al.
Publicado: (2018)

Modified aptamers as reagents to characterize recombinant human erythropoietin products
por: Jankowski, Wojciech, et al.
Publicado: (2020)

Cross-platform transcriptomic profiling of the response to recombinant human erythropoietin
por: Wang, Guan, et al.
Publicado: (2021)

Cost-effectiveness of continuous erythropoietin receptor activator in anemia
por: Schmid, Holger
Publicado: (2014)

Erythropoietin Levels in Elderly Patients with Anemia of Unknown Etiology
por: Gowanlock, Zachary, et al.
Publicado: (2016)

Burden of Anemia in Chronic Kidney Disease: Beyond Erythropoietin
por: Hanna, Ramy M., et al.
Publicado: (2020)

Erythropoietin in bone homeostasis—Implications for efficacious anemia therapy
por: Lappin, Katrina M., et al.
Publicado: (2021)

Serum Erythropoietin level in anemia of elderly with unclear etiology
por: Seong, Ju Yong, et al.
Publicado: (2023)

The effect of recombinant human erythropoietin treatment on tumour radiosensitivity and cancer-associated anaemia in the mouse.
por: Joiner, B., et al.
Publicado: (1993)

Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia.
por: Barosi, G., et al.
Publicado: (1998)

Cytoprotective Effect of Recombinant Human Erythropoietin Produced in Transgenic Tobacco Plants
por: Kittur, Farooqahmed S., et al.
Publicado: (2013)

Recombinant human erythropoietin improves neurological outcomes in very preterm infants
por: Song, Juan, et al.
Publicado: (2016)

Transcriptomic Markers of Recombinant Human Erythropoietin Micro-Dosing in Thoroughbred Horses
por: Dahlgren, Anna R., et al.
Publicado: (2021)

Recombinant human epoetin beta in the treatment of renal anemia
por: Locatelli, Francesco, et al.
Publicado: (2007)

Anemia and blood transfusion in the critically ill patient: role of erythropoietin
por: Corwin, Howard L
Publicado: (2004)

Erythropoietin stimulating agents in the management of anemia of chronic kidney disease
por: Hayat, Amir, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_kvjrc9spblthbt5j1ukv0b1pvo